2,305
Views
19
CrossRef citations to date
0
Altmetric
Research Article

Antiepileptic activity of total triterpenes isolated from Poria cocos is mediated by suppression of aspartic and glutamic acids in the brain

, , &
Pages 2528-2535 | Received 30 Jun 2015, Accepted 17 Mar 2016, Published online: 09 May 2016

References

  • Ahmadiani A, Mandgary A, Sayyah M. 2003. Anticonvulsant effect of flutamide on seizures induced by pentylenetetrazole: involvement of benzodiazepine receptors. Epilepsia. 44:629–635.
  • Albrecht J, Sidoryk-Wegrzynowicz M, Zielinska M, Aschner M. 2010. Roles of glutamine in neurotransmission. Neuron Glia Biol. 6:263–276.
  • Alexopoulos H, Dalakas MC. 2013. Immunology of stiff person syndrome and other GAD-associated neurological disorders. Expert Rev Clin Immunol. 9:1043–1053.
  • Awad R, Ahmed F, Bourbonnais-Spear N, Mullally M, Ta CA, Tang A, Merali Z, Maquin P, Caal F, Cal V, et al. 2009. Ethnopharmacology of Q'eqchi' Maya antiepileptic and anxiolytic plants: effects on the GABAergic system. J Ethnopharmacol. 125:257–264.
  • Beghi E, Hesdorffer D. 2014. Prevalence of epilepsy – an unknown quantity. Epilepsia. 55:963–967.
  • Benamer HT, Grosset DG. 2009. A systematic review of the epidemiology of epilepsy in Arab countries. Epilepsia. 50:2301–2304.
  • Blanco MM, dos Santos JG Jr, Perez-Mendes P, Kohek SR, Cavarsan CF, Hummel M, Albuquerque C, Mello LE. 2009. Assessment of seizure susceptibility in pilocarpine epileptic and nonepileptic Wistar rats and of seizure reinduction with pentylenetetrazole and electroshock models. Epilepsia. 50:824–831.
  • Bonanno G, Raiteri L, Paluzzi S, Zappettini S, Usai C, Raiteri M. 2006. Co-existence of GABA and Glu transporters in the central nervous system. Curr Top Med Chem. 6:979–988.
  • Chan K, Shaw D, Simmonds M, Leon CJ, Xu Q, Lu A, Sutherland I, Ignatova S, Zhu YP, Verpoorte R, et al. 2012. Good practice in reviewing and publishing studies on herbal medicine, with special emphasis on traditional Chinese medicine and Chinese materia medica. J Ethnopharmacol. 140:469–475.
  • Chen L, Wang D, Wu J, Yu B, Zhu D. 2009. Identification of multiple constituents in the traditional Chinese medicine formula GuiZhiFuLing-Wan by HPLC-DAD-MS/MS. J Pharm Biomed Anal. 49:267–275.
  • Chindo BA, Ya UJ, Danjuma NM, Okhale SE, Gamaniel KS, Becker A. 2014. Behavioral and anticonvulsant effects of the standardized extract of Ficus platyphylla stem bark. J Ethnopharmacol. 154:351–360.
  • Clancy MJ, Clarke MC, Connor DJ, Cannon M, Cotter DR. 2014. The prevalence of psychosis in epilepsy; a systematic review and meta-analysis. BMC Psychiatry. 14:75.
  • Cuellar MJ, Giner RM, Recio MC, Just MJ, Mañez S, Rios JL. 1997. Effect of the basidiomycete Poria cocos on experimental dermatitis and other inflammatory conditions. Chem Pharm Bull. 45:492–494.
  • Dong H, Wu P, Yan R, Xu Q, Li H, Zhang F, Li J, Yang B. 2015. Enrichment and separation of antitumor triterpene acids from the epidermis of Poria cocos by pH-zone-refining counter-current chromatography and conventional high-speed counter-current chromatography. J Sep Sci. 38:1977–1982.
  • Duncan JS, Sander JW, Sisodiya SM, Walker MC. 2006. Adult epilepsy. Lancet. 367:1087–1100.
  • Enell L, Hamasaka Y, Kolodziejczyk A, Nässel DR. 2007. Gamma-Aminobutyric acid (GABA) signaling components in Drosophila: immunocytochemical localization of GABA(B) receptors in relation to the GABA(A) receptor subunit RDL and a vesicular GABA transporter. J Comp Neurol. 505:18–31.
  • Feng YL, Lei P, Tian T, Yin L, Chen DQ, Chen H, Mei Q, Zhao YY, Lin RC. 2013a. Diuretic activity of some fractions of the epidermis of Poria cocos. J Ethnopharmacol. 150:1114–1118.
  • Feng YL, Zhao YY, Ding F, Xi ZH, Tian T, Zhou F, Du X, Chen DQ, Wei F, Cheng XL, et al. 2013b. Chemical constituents of surface layer of Poria cocos and their pharmacological properties (I). Zhongguo Zhong Yao Za Zhi. 38:1098–1102.
  • Forsgren L, Hauser WA, Olafsson E, Sander JW, Sillanpää M, Tomson T. 2005. Mortality of epilepsy in developed countries: a review. Epilepsia. 46:18–27.
  • Garzon-Dela Mora P, Garcia-Lopez PM, Garcia-Estrada J, Navarro-Ruíz A, Villanueva-Michel T, Villarreal-de Puga LM, Casillass-Ochoa J. 1999. Casimiroa edulis seed extracts show anticonvulsive properties in rats. J Ethnopharmacol. 68:275–282.
  • Giner EM, Manez S, Recio MC, Giner RM, Cerdá-Nicolás M, Ríos JL. 2000. In vivo studies on the anti-inflammatory activity of pachymic and dehydrotumulosic acids. Planta Med. 66:221–227.
  • Greenfield LJ Jr. 2013. Molecular mechanisms of antiseizure drug activity at GABAA receptors. Seizure. 22:589–600.
  • Kang BK, Park TY, Lee JA, Moon TW, Lee MS. 2015. Factor analysis on symptoms and signs of stroke based on traditional Korean Medicine theory. Int J Clin Exp Med. 8:949–960.
  • Kaufman KR. 2011. Antiepileptic drugs in the treatment of psychiatric disorders. Epilepsy Behav. 21:1–11.
  • Krall RL, Penry JK, White BG, Kupferberg HJ, Swinyard EA. 1978. Antiepileptic drug development: II. Anticonvulsant drug screening. Epilepsia. 19:409–428.
  • Laxer KD, Trinka E, Hirsch LJ, Cendes F, Langfitt J, Delanty N, Resnick T, Benbadis SR. 2014. The consequences of refractory epilepsy and its treatment. Epilepsy Behav. 37:59–70.
  • Lee HC, Cheng WY, Huang BETG, Hsu YH, Huang SY. 2014. Anti-inflammatory and hypoglycemic efficacy of Poria cocos and Dioscorea opposita in prediabetes mellitus rats. RSC Adv. 4:55649–55657.
  • Luttjohann A, Fabene PF, van Luijtelaar G. 2009. A revised Racine's scale for PTZ-induced seizures in rats. Physiol Behav. 98:579–586.
  • Madsen KK, White HS, Schousboe A. 2010. Neuronal and non-neuronal GABA transporters as targets for antiepileptic drugs. Pharmacol Ther. 125:394–401.
  • Maguire MJ, Weston J, Singh J, Marson AG. 2014. Antidepressants for people with epilepsy and depression. Cochrane Database Syst Rev. 12:CD010682.
  • Malagon-Valdez J. 2004. The new antiepileptic drugs: their indications and side effects. Rev Neurol. 39:570–575.
  • Miczek KA, Fish EW, De Bold JF, De Almeida RM. 2002. Social and neural determinants of aggressive behavior: pharmacotherapeutic targets at serotonin, dopamine and gamma-aminobutyric acid systems. Psychopharmacology (Berl). 163:434–458.
  • Moshe SL, Perucca E, Ryvlin P, Tomson T. 2015. Epilepsy: new advances. Lancet. 385:884–898.
  • Murillo-Rodriguez E, Arias-Carrion O, Zavala-Garcia A, Sarro-Ramirez A, Huitron-Resendiz S, Arankowsky-Sandoval G. 2012. Basic sleep mechanisms: an integrative review. Cent Nerv Syst Agents Med Chem. 12:38–54.
  • Newton CR, Garcia HH. 2012. Epilepsy in poor regions of the world. Lancet. 380:1193–1201.
  • Noam Y, Raol YH, Holmes GL. 2013. Searching for new targets for treatment of pediatric epilepsy. Epilepsy Behav. 26:253–260.
  • Perez RM, Perez JA, Garcia LM, Sossa H. 1998. Neuropharmacological activity of Solanum nigrum fruit. J Ethnopharmacol. 62:43–48.
  • Rios JL. 2011. Chemical constituents and pharmacological properties of Poria cocos. Planta Med. 77:681–691.
  • Ruthrich H, Grecksch G, Krug M. 2001. Development of long-lasting potentiation effects in the dentate gyrus during pentylenetetrazol kindling. Int J Dev Neurosci. 19:247–254.
  • Schousboe A, Madsen KK, White HS. 2011. GABA transport inhibitors and seizure protection: the past and future. Future Med Chem. 3:183–187.
  • Song PP, Gao JJ, Kokudo N, Tang W. 2011. Standardization of traditional Chinese medicine and evaluation of evidence from its clinical practice. Drug Discov Ther. 5:261–265.
  • Spelman K, Burns J, Nichols D, Winters N, Ottersberg S, Tenborg M. 2006. Modulation of cytokine expression by traditional medicines: a review of herbal immunomodulators. Altern Med Rev. 11:128–150.
  • Tai T, Akahori A, Shingu T. 1993. Triterpenses of Poria cocos. Phytochemistry. 32:1239–1244.
  • Takechi K, Suemaru K, Kawasaki H, Araki H. 2012. Impaired memory following repeated pentylenetetrazol treatments in kindled mice. Yakugaku Zasshi. 132:179–182.
  • Temkin NR. 2009. Preventing and treating posttraumatic seizures: the human experience. Epilepsia. 50:10–13.
  • Ueki T, Mizoguchi K, Yamaguchi T, Nishi A, Sekiguchi K, Ikarashi Y, Kase Y. 2015. Yokukansan, a traditional Japanese medicine, decreases head-twitch behaviors and serotonin 2A receptors in the prefrontal cortex of isolation-stressed mice. J Ethnopharmacol. 166:23–30.
  • Wambebe C. 1985. Influence of some agents that affect 5-hydroxytryptamine metabolism and receptors on nitrazepam-induced sleep in mice. Br J Pharmacol. 84:185–191.
  • Wang W, Dong H, Yan R, Li H, Li P, Chen P, Yang B, Wang Z. 2015. Comparative study of lanostane-type triterpene acids in different parts of Poria cocos (Schw.) Wolf by UHPLC-Fourier transform MS and UHPLC-triple quadruple MS. J Pharm Biomed Anal. 102:203–214.
  • Xiang J, Jiang Y. 2013. Antiepileptic potential of matrine via regulation the levels of gamma-aminobutyric acid and glutamic acid in the brain. Int J Mol Sci. 14:23751–23761.
  • Yang T, Kong B, Gu JW, Kuang YQ, Cheng L, Yang WT, Cheng JM, Ma Y, Yang XK. 2013. Anticonvulsant and sedative effects of paederosidic acid isolated from Paederia scandens (Lour.) Merrill. in mice and rats. Pharmacol Biochem Behav. 111:97–101.
  • Zhao YY, Feng YL, Bai X, Tan XJ, Lin RC, Mei Q. 2013a. Ultra performance liquid chromatography-based metabonomic study of therapeutic effect of the surface layer of Poria cocos on adenine-induced chronic kidney disease provides new insight into anti-fibrosis mechanism. PLoS One. 8:e59617.
  • ZhaoYY, FengYL, DuX, Xi ZH, Cheng XL, Wei F. 2012. Diuretic activity of the ethanol and aqueous extracts of the surface layer of Poria cocos in rat. J Ethnopharmacol. 144:775–778.
  • Zhao YY, Lei P, Chen DQ, Feng YL, Bai X. 2013b. Renal metabolic profiling of early renal injury and renoprotective effects of Poria cocos epidermis using UPLC Q-TOF/HSMS/MSE. J Pharm Biomed Anal. 202–209:81–82.
  • Zhao YY, Li HT, Feng YL, Bai X, Lin RC. 2013c. Urinary metabonomic study of the surface layer of Poria cocos as an effective treatment for chronic renal injury in rats. J Ethnopharmacol. 148:403–410.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.